Developed by Afreximbank in partnership with King’s College Hospital, London, AMCE was established to help transform specialist healthcare delivery in Africa, by strengthening clinical capacity, advancing research and education, creating a sustainable ecosystem for world-class care on the continent and in turn, reducing dependence on medical travel abroad.

In its first year of operation, AMCE has moved from vision to measurable impact, demonstrating how development finance can transform healthcare on the continent.

The Centre has registered over 5,000 patients from more than 20 countries across four continents, underscoring its growing role as a regional and global referral centre for advanced specialist healthcare.

Beyond the numbers are lives already being transformed. During its first year, AMCE has achieved several important clinical milestones. The Centre delivered West Africa’s first Stereotactic Body Radiation Therapy (SBRT) for lung cancer, treating an octogenarian with a localised lung tumour using a highly precise, non-invasive technique that previously required many patients to travel abroad. The Centre also completed its first complex Triple Coronary Artery Bypass Grafting (CABG), demonstrating that advanced cardiac care can now be delivered to global standards within Africa. AMCE also successfully completed two Stem cell transplants.

Its advanced laboratory has processed more than 40,000 diagnostic tests and investigations, completed 10 open-heart surgeries and 11 cardiac surgical procedures under the cardiac programme, administered 99 catheterisation laboratory procedures, and 173 anaesthesia-supported procedures in just a year.

Additionally, the Centre has commenced Nuclear medicine services, with Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) imaging now available for bone scans, renograms, and perfusion scans, while Positron Emission Tomography/Computed Tomography (PET/CT) imaging is scheduled to commence later in the year.

Speaking during the visit, Dr. Elombi applauded the remarkable progress recorded by the Centre within its first year of operation, describing it as a compelling demonstration of African excellence, institutional resolve, and shared purpose. He stated: “The success of this Centre reflects the depth of talent assembled here and the pan-African spirit that underpins its service. The vision that inspired the conception and construction of this facility is the same conviction now being carried forward by the medical professionals delivering care to the continent. The AMCE provides health services and advances Africa’s health sovereignty while affirming our collective capacity to take responsibility for our own lives and future. The AMCE is a world-class quaternary healthcare facility delivering medical services of a standard that many would previously have sought beyond the continent. Nigerians, and citizens across Africa, must take full advantage of this facility—built by African institutions with the steadfast support of our governments.”

AMCE Chief Executive Officer, Brian Deaver, said Dr. Elombi’s visit marks an important milestone in the Centre’s journey and provides an opportunity to reflect on the impact AMCE has made in just one year.

“Our progress, from pioneering clinical achievements to earning growing trust across the region, demonstrates that Africa can build and sustain world-class centres of excellence. With Afreximbank’s continued vision and support, we remain committed to advancing patient care, research, education and innovation to strengthen health systems across the continent”.  Deaver noted.

Dr Elombi also toured key clinical departments, interacted with healthcare professionals and staff, and received updates on the Centre’s operational performance, clinical achievements and long-term expansion plans. He thanked the facilities’ employees for their commitment to building a new benchmark for specialist healthcare in Africa, noting that the Centre’s early achievements reflect the dedication, professionalism and shared vision of its workforce.

Today, AMCE employs more than 600 clinical and non-clinical professionals, representing 12 nationalities, and reflecting its growing reputation as a destination for highly skilled healthcare professionals. Earlier this year, the Centre also earned Great Place to Work® Certification, with 90 percent of employees affirming it is a great place to work.

Vestergaard first rehabilitated the Emusanda Health Centre in Lurambi, Kenya, in 2009, establishing a community clinic delivering essential primary and paediatric care, and comprehensive services for people living with HIV. Since LifeStraw became an independent company in 2020, it has continued to develop the facility – building a maternity ward and strengthening pre- and postnatal services – while Vestergaard has provided mosquito nets for every mother giving birth at the centre, and every family with children under 5 years old accessing care. Each family also receives a LifeStraw household water purifier, and LifeStraw’s local teams continue to support the clinic by filling staffing gaps and supplying essential medicines so services can operate around the clock.

Beyond Emusanda, LifeStraw’s Give Back programme has delivered safe water to schools and communities across Kenya and other countries, reaching more than 14 million children. At the same time, malaria remains a major threat to child health, with over 4 million cases estimated nationwide in 2024. Insecticide‑treated nets have been instrumental in reducing malaria globally, accounting for 72% (https://apo-opa.co/4vuLfIc) of all cases prevented between 2000 and 2024, while next‑generation dual active‑ingredient nets including PermaNet Dual have stopped an estimated 40 million cases since their introduction in 2019.

By integrating distribution of Vestergaard’s latest mosquito net technology into LifeStraw’s existing community health programmes, the annual donation of PermaNet Dual will extend protection beyond healthcare facilities to boarding schools caring for orphans and children with disabilities, ensuring safer nights for some of the most at risk. Together, safe drinking water and malaria prevention form a simple but powerful package of protection for mothers, newborns, and school‑aged children.

Amar Ali, CEO of Vestergaard, said: “LifeStraw’s frontline work continues to show where the gaps are, and how well‑targeted interventions can protect children who might otherwise be left behind. By formalizing this annual PermaNet donation, we’re reinforcing our shared commitment to helping communities access the basic tools they need for a safer and healthier start in life.”

Alison Hill, CEO of LifeStraw, said: “Safe water and malaria prevention are two of the most fundamental building blocks of community health, yet too many families still lack consistent access to either. LifeStraw’s mission has always been rooted in the belief that safe water is a foundation for health and opportunity, but water alone is not enough. By integrating Vestergaard’s PermaNet Dual into our programs, we are bringing together the right interventions for families and children, improving both health and educational outcomes. It is a practical, scalable approach grounded in decades of work in these communities.”